Pfizer vaccine: Rates of deep vein thrombosis and thrombocytopenia after vaccine increase

AS MANY as 32 million people across the UK will be offered the COVID-19 vaccine in a bid to boost immunity ahead of winter. Although the Pfizer vaccine has proven highly effective at preventing serious illness from COVID-19, a recent study has suggested the jab could carry the rare risk of thrombocytopenia and deep vein thrombosis .
Daily Express :: Health Feed